NCT04047485

Brief Summary

The study intends to measure the evolution over time of the cognitive capacity of patients undergoing cataract surgery in relation to the opaque lens removal surgery (cataract) in a population considered to be at risk of neurocognitive degeneration. Secondary objectives:

  • Estimate the incidence of postoperative cognitive dysfunctions and any episodes of perioperative delirium with the aim of demonstrating the safety of cataract surgery in the elderly patient in terms of cognitive functions and impact on the psychological state. In the context of the study a risk sub-population analysis will be carried out, evaluating the trend over time of the "endothelial cells count" parameter The elderly population remains, due to the aging of the cornea, a population "at risk" for significant alterations from the clinical point of view. During the study the endothelial cells count will be monitored, in order to be able to evaluate the safety of the cataract surgery and to be able to correctly correlate a possible deterioration in the visual acuity of patients with corneal decompensation. To evaluate the progress of the endothelial cells count in the elderly patient during the pre-intervention and post-intervention period. Since the low values of cellular media in endothelial microscopy are an element that increases the risk of complications during cataract surgery, the study wants to assess how waiting times between filter visits and cataract surgery can cause an elderly patient worsening of this parameter even in a few months. The trend of the same parameter will be monitored even after the intervention since in case of decrease, the low endothelial count could cause an alteration of visual acuity and therefore a minor improvement in cognitive performance. The research will be set as a longitudinal observational study where will be compared in each patient the parameters analyzed in the 6 months prior to cataract surgery and in the 3 months following the operation itself. Patients will be enrolled during the first cataract filter visit, will be submitted to simple questions and their clinical data will be collected. Subsequently, before and after three months of surgery repeated cognitive testing and the control normally performed instrumental tests during follow-up. A clinical follow-up will be provided, during normal follow-up visits at 20 days and 6 months after the patient's surgery: the following information will be collected during these visits
  • BCVA (visual acuity)
  • endothelial cells microscopy
  • OCT macula and optic nerve
  • Catquest 9SF;
  • Barthel Index;
  • Six Item Cognitive Test
  • Confusion Assessment Method (CAM): this exam will be performed within 24 hours of post-surgery and 20 days after surgery. It is important to underline that the cognitive tests proposed to patients consist of simple questions that do not depend on the visual ability of the subject.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 2, 2019

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 25, 2019

Completed
12 days until next milestone

First Posted

Study publicly available on registry

August 6, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2020

Completed
Last Updated

August 6, 2019

Status Verified

August 1, 2019

Enrollment Period

1.1 years

First QC Date

July 25, 2019

Last Update Submit

August 5, 2019

Conditions

Keywords

CataractMild Cognitive Impairment (MCI)Cataract SurgeryBMICS (Bi-Manual Microincisional Cataract Surgery)Post-operative Delirium

Outcome Measures

Primary Outcomes (1)

  • Correlation between visual acuity and cognitive function at 3 months after Cataract Surgery.

    The visual acuity trend and the cognitive function using the Kingshill (6CIT) score are measured during every visit. The 6 Item Cognitive Impairment Test (6CIT) is a test that doesn't provide the visual function. The choice of this kind of test resides in the capability of evaluating the cognitive function without any influence caused by cataract. The score is composed by 6 questions which evaluate the work memory, the temporal and spatial orientation. The test's result is a score, with a clinical cut-off of 7 points. The more points the subject makes, the higher risk of cognitive impairment is configured. The visual acuity is calculated with Snellen Chart using the Best Corrected Visual Acuity (BCVA) with the number of letters read.

    6 months before surgery to 3 months after surgey

Secondary Outcomes (3)

  • Post operative delirium prevalence

    Only during the perioperative period (day of cataract surgery and the next 48 hours)

  • Corneal endothelial cells density

    6 months before surgery, 20 days after cataract surgery and 3 months after cataract surgery.

  • Corneal pachymetry

    6 months before surgery, 20 days after cataract surgery and 3 months after cataract surgery.

Study Arms (4)

Elderly Female (A)

Female subjects between 65 and 85 years old

Diagnostic Test: Visual AcuityDiagnostic Test: CAM (Confusion Assesment Method)Diagnostic Test: CATQUEST 9-SFDiagnostic Test: OCTDiagnostic Test: 6CITDiagnostic Test: Barthel IndexDiagnostic Test: Endothelial Microscopy - Cornea

Great Elderly Female (B)

Female subjects with more than 85 years old

Diagnostic Test: Visual AcuityDiagnostic Test: CAM (Confusion Assesment Method)Diagnostic Test: CATQUEST 9-SFDiagnostic Test: OCTDiagnostic Test: 6CITDiagnostic Test: Barthel IndexDiagnostic Test: Endothelial Microscopy - Cornea

Elderly Male (C)

Male subjects between 65 and 81 years old

Diagnostic Test: Visual AcuityDiagnostic Test: CAM (Confusion Assesment Method)Diagnostic Test: CATQUEST 9-SFDiagnostic Test: OCTDiagnostic Test: 6CITDiagnostic Test: Barthel IndexDiagnostic Test: Endothelial Microscopy - Cornea

Great Elderly Male (D)

Men subjects with more than 81 years old

Diagnostic Test: Visual AcuityDiagnostic Test: CAM (Confusion Assesment Method)Diagnostic Test: CATQUEST 9-SFDiagnostic Test: OCTDiagnostic Test: 6CITDiagnostic Test: Barthel IndexDiagnostic Test: Endothelial Microscopy - Cornea

Interventions

Visual AcuityDIAGNOSTIC_TEST

During T0, T2 and T3, every subject has been evaluated with a Snellen Chart, to measure visual acuity in number of letters (BVCA)

Elderly Female (A)Elderly Male (C)Great Elderly Female (B)Great Elderly Male (D)

During the first 48 hours of post-op follow-up, any episode of "post-operative Delirium" is checked and evaluated.

Elderly Female (A)Elderly Male (C)Great Elderly Female (B)Great Elderly Male (D)
CATQUEST 9-SFDIAGNOSTIC_TEST

The questionnaire contains questions evaluating the benefits of cataract surgery. The questionnaire has been used during T0, T2 and T3

Elderly Female (A)Elderly Male (C)Great Elderly Female (B)Great Elderly Male (D)
OCTDIAGNOSTIC_TEST

Using the RNFL and the Macular Topography protocol, the macula and optical nerve are measured during the T2 phase of each patient the risk of Irvine Gas's syndrome or any other retinal complication.

Also known as: Optical Coherence Tomography
Elderly Female (A)Elderly Male (C)Great Elderly Female (B)Great Elderly Male (D)
6CITDIAGNOSTIC_TEST

This Cognitive Impairment test doesn't require Visual function to be executed. Cognitive function is evaluated at T0, T1 and the post-operative trend at T2 and T3.

Also known as: Kingship Test
Elderly Female (A)Elderly Male (C)Great Elderly Female (B)Great Elderly Male (D)
Barthel IndexDIAGNOSTIC_TEST

To evaluate the everyday independence of the subject and it's trend durin the follow-up

Elderly Female (A)Elderly Male (C)Great Elderly Female (B)Great Elderly Male (D)

Endothelial cell density is evaluated before surgery (T0) and during the follow-up (T2 and T3). The reason of the choice of this test is to evaluate the trend of these instrumental parameters in the elderly population.

Elderly Female (A)Elderly Male (C)Great Elderly Female (B)Great Elderly Male (D)

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The studied population consists in people who can really obtain a visual acuity recovery with cataract surgery. All the variables are measured in a very elderly population (high risk population) and compared them in a elderly population (lower risk)

You may qualify if:

  • Patients with age ≥ 65 years undergoing cataract surgery. Cataract surgery is indicated by the medical-scientific community according to good clinical practice and not influenced by the study's criteria. The purpose of the study is to add clinical-scientific information of any relevance.

You may not qualify if:

  • Patient refusal
  • Diagnosis of dementia by the specialist in neurocognitive diseases (neurologist and / or geriatrician)
  • maculopaties and other ophthalmopaties (according to diagnosis of ophthalmologist specialist) because the visual capacity is invalidated regardless of the opacification of the crystalline and therefore the cognitive function is not affected by a post-intervention improvement.
  • Patients who have performed cataract surgery in at least one eye since the previous cataract operation may have already caused changes in cognitive function causing confusion about the results of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Policlinico di Modena

Modena, 41124, Italy

Location

Related Publications (8)

  • Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M; Alzheimer's Disease International. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005 Dec 17;366(9503):2112-7. doi: 10.1016/S0140-6736(05)67889-0.

    PMID: 16360788BACKGROUND
  • Jefferis JM, Mosimann UP, Clarke MP. Cataract and cognitive impairment: a review of the literature. Br J Ophthalmol. 2011 Jan;95(1):17-23. doi: 10.1136/bjo.2009.165902. Epub 2010 Aug 31.

    PMID: 20807709BACKGROUND
  • Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 2007 Jul;3(3):186-91. doi: 10.1016/j.jalz.2007.04.381.

    PMID: 19595937BACKGROUND
  • Taiel-Sartral M, Nounou P, Rea C, el Alamy A, Bendeddouche K, Boumezrag M, Milcamps R, Cohen D. [Visual acuity and ocular diseases in aged residents of nursing homes: study of 219 persons in Orleans]. J Fr Ophtalmol. 1999 May;22(4):431-7. French.

    PMID: 10365330BACKGROUND
  • Oeppen J, Vaupel JW. Demography. Broken limits to life expectancy. Science. 2002 May 10;296(5570):1029-31. doi: 10.1126/science.1069675. No abstract available.

    PMID: 12004104BACKGROUND
  • Lawrence D, Fedorowicz Z, van Zuuren EJ. Day care versus in-patient surgery for age-related cataract. Cochrane Database Syst Rev. 2015 Nov 2;2015(11):CD004242. doi: 10.1002/14651858.CD004242.pub5.

    PMID: 26524611BACKGROUND
  • Laidlaw DA, Harrad RA, Hopper CD, Whitaker A, Donovan JL, Brookes ST, Marsh GW, Peters TJ, Sparrow JM, Frankel SJ. Randomised trial of effectiveness of second eye cataract surgery. Lancet. 1998 Sep 19;352(9132):925-9. doi: 10.1016/s0140-6736(97)12536-3.

    PMID: 9752814BACKGROUND
  • Westcott MC, Tuft SJ, Minassian DC. Effect of age on visual outcome following cataract extraction. Br J Ophthalmol. 2000 Dec;84(12):1380-2. doi: 10.1136/bjo.84.12.1380.

    PMID: 11090477BACKGROUND

MeSH Terms

Conditions

DementiaCognitive DysfunctionCataractConfusionPostoperative ComplicationsEmergence Delirium

Interventions

Visual AcuityTomography, Optical Coherence

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental DisordersCognition DisordersLens DiseasesEye DiseasesNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPathologic ProcessesDelirium

Intervention Hierarchy (Ancestors)

Vision TestsDiagnostic Techniques, OphthalmologicalDiagnostic Techniques and ProceduresDiagnosisOcular Physiological PhenomenaTomography, OpticalOptical ImagingDiagnostic ImagingTomographyInvestigative Techniques

Study Officials

  • Gian Maria Cavallini, Associate Professor

    Dipartimento Chirurgico, Medico, Odontoiatrico e di Scienze Morfologiche con interesse Trapiantologico, Oncologico e di Medicina Rigenerativa - UNIMORE - University of Modena and Reggio Emilia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Head of Ophthalmology, Director, School of Specialization in Ophthalmology.

Study Record Dates

First Submitted

July 25, 2019

First Posted

August 6, 2019

Study Start

February 2, 2019

Primary Completion

February 28, 2020

Study Completion

March 30, 2020

Last Updated

August 6, 2019

Record last verified: 2019-08

Locations